| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000023369 |
| Receipt No. | R000026925 |
| Official scientific title of the study | Blood pressure study in Japanese Parkinson's disease patients |
| Date of disclosure of the study information | 2016/09/01 |
| Last modified on | 2016/07/28 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Blood pressure study in Japanese Parkinson's disease patients | |
| Title of the study (Brief title) | ABPM Study in Japanese PD | |
| Region |
|
|
| Condition | ||
| Condition | Parkinson's disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To clarify the change in blood pressure of Japanese Parkinson disease patients. The results were compared with the clinical information of the patient. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | We evaluate the relationship between clinical information of PD patients and 24h ABPM data. |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Japanese Parkinson's disease patients
1) age >=30 years, 2) Japanese PD patients who has been diagnosed by UKPDBB criteria 3) mini mental state examination score >= 23 4) the patients who their informed consent has been obtained |
|||
| Key exclusion criteria | 1) dementia and depression/psychiatric illness (according to DSM IV criteria),
2) all secondary causes of parkinsonism, epilepsy, history of other neurological disorders, stroke and/or brain trauma and drug or alcohol abuse. 3) diabetes mellitus, autonomic failure |
|||
| Target sample size | 216 | |||
| Research contact person | |
| Name of lead principal investigator | Renpei Sengoku |
| Organization | Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology |
| Division name | Neurology |
| Address | 35-2 Sakae-cho, Itabashi-ku, Tokyo |
| TEL | 03-3964-1141 |
| renpeis@gmail.com | |
| Public contact | |
| Name of contact person | Renpei Sengoku |
| Organization | Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology |
| Division name | Neurology |
| Address | 35-2 Sakae-cho, Itabashi-ku, Tokyo |
| TEL | 03-3964-1141 |
| Homepage URL | |
| renepis@gmail.com | |
| Sponsor | |
| Institute | Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | This is a Japanese multi-center study for evaluating blood pressure of Parkinson's disease patients.
We evaluate the correlation between 24h ABPM data and clinical information. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026925 |